| pubmed-article:8147264 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8147264 | lifeskim:mentions | umls-concept:C0033809 | lld:lifeskim |
| pubmed-article:8147264 | lifeskim:mentions | umls-concept:C0027950 | lld:lifeskim |
| pubmed-article:8147264 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:8147264 | lifeskim:mentions | umls-concept:C0085387 | lld:lifeskim |
| pubmed-article:8147264 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8147264 | lifeskim:mentions | umls-concept:C1326500 | lld:lifeskim |
| pubmed-article:8147264 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:8147264 | lifeskim:mentions | umls-concept:C0608211 | lld:lifeskim |
| pubmed-article:8147264 | pubmed:issue | 1-2 | lld:pubmed |
| pubmed-article:8147264 | pubmed:dateCreated | 1994-5-5 | lld:pubmed |
| pubmed-article:8147264 | pubmed:abstractText | Pseudomonas aeruginosa chemotactic peptides (PAPCs) induced migration of polymorphonuclear leukocytes (PMNL) into the lungs when administered by the aerosol route. Migration of PMNL into the lungs and total protein content of lung lavage fluids in response to PAPCs aerosol challenge, and mortality from lethal challenge with P. aeruginosa were decreased by piroxicam treatment. | lld:pubmed |
| pubmed-article:8147264 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8147264 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8147264 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8147264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8147264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8147264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8147264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8147264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8147264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8147264 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8147264 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:8147264 | pubmed:issn | 0065-4299 | lld:pubmed |
| pubmed-article:8147264 | pubmed:author | pubmed-author:SordelliD ODO | lld:pubmed |
| pubmed-article:8147264 | pubmed:author | pubmed-author:FontánP APA | lld:pubmed |
| pubmed-article:8147264 | pubmed:author | pubmed-author:AmuraC RCR | lld:pubmed |
| pubmed-article:8147264 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8147264 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:8147264 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8147264 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8147264 | pubmed:pagination | 106-9 | lld:pubmed |
| pubmed-article:8147264 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:meshHeading | pubmed-meshheading:8147264-... | lld:pubmed |
| pubmed-article:8147264 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8147264 | pubmed:articleTitle | The effect of a cyclooxygenase inhibitor on the in vivo polymorphonuclear leukocyte migration to Pseudomonas aeruginosa peptide chemotactins. | lld:pubmed |
| pubmed-article:8147264 | pubmed:affiliation | Departamento de Microbiología, Parasitología and Immunología, Facultad de Medicina, Universidad de Buenos Aires, Argentina. | lld:pubmed |
| pubmed-article:8147264 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8147264 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
